Mylan Inc. (MYL) said its Canadian subsidiary, Mylan Pharmaceuticals ULC, has received approval from Health Canada for Mylan-Bosentan Tablets, 62.5 mg and 125 mg.
Mylan-Bosentan is the generic version of Actelion Pharmaceuticals Ltd.'s Tracleer, used for the treatment of pulmonary arterial hypertension.
"Providing Canadians access to high quality, affordable medicines is our primary goal," said Dick Guest, Mylan Canada's President and CEO. "By providing access to more affordable generic drugs, Mylan helps to reduce the burden on our health care system, benefiting all Canadians."
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.